STOCK TITAN

Agilent Technologies Inc - A STOCK NEWS

Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.

Overview of Agilent Technologies Inc.

Agilent Technologies Inc. (NYSE: A) is a global leader in providing innovative solutions for the life sciences, diagnostics, and applied chemical markets. Originally spun out of Hewlett-Packard in 1999, Agilent has established itself as a trusted partner for analytical scientists and clinical researchers worldwide. The company delivers a comprehensive portfolio of laboratory instruments, software, services, and consumables designed to meet the complex needs of its customers, who operate in industries such as pharmaceuticals, environmental testing, food safety, medical diagnostics, and academic research.

Core Business Segments

Agilent operates through three primary business segments:

  • Life Sciences and Applied Markets: This segment focuses on providing advanced measurement tools and technologies that enable breakthroughs in biopharmaceuticals, chemical analysis, and advanced materials science.
  • Diagnostics and Genomics: Supporting clinical and molecular diagnostics, this segment delivers solutions that address critical healthcare needs, including cancer research and genetic testing.
  • CrossLab Group: Offering consumables, services, and software, this segment ensures laboratory efficiency and seamless operation across the entire workflow, from sample preparation to data analysis.

Market Position and Industry Significance

Agilent's solutions address the full spectrum of laboratory needs, making it a vital partner for organizations tackling global challenges in health, safety, and environmental sustainability. Over half of its revenue is derived from the biopharmaceutical, chemical, and advanced materials industries, which are considered highly stable and 'sticky' markets due to their critical nature. Additionally, Agilent supports a diverse customer base, including clinical labs, government agencies, and academic institutions, further underscoring its broad market relevance.

Geographical Reach and Innovation

With operations spanning the globe, Agilent maintains a strong presence in the United States and China, its two largest markets. The company’s commitment to innovation is evident in its ability to anticipate future scientific needs and address emerging trends. By integrating cutting-edge technologies and leveraging decades of expertise, Agilent empowers its customers to achieve better outcomes and drive progress in their respective fields.

Value Proposition

Agilent’s unique value proposition lies in its ability to improve laboratory efficiency and productivity across the entire workflow. From sample preparation to data interpretation, its solutions enable customers to generate actionable insights that drive scientific discovery and enhance human and environmental health. Customers trust Agilent for its reliability, precision, and commitment to delivering solutions that make a measurable impact on the world.

Conclusion

Agilent Technologies Inc. is more than a provider of laboratory solutions; it is a key enabler of scientific progress. By addressing the evolving needs of its diverse customer base and leveraging its deep expertise, Agilent continues to play a pivotal role in advancing research, diagnostics, and applied science globally.

Rhea-AI Summary
Crawford & Company (NYSE: CRD-A and CRD-B) has declared a quarterly dividend of $0.07 per share on the Class A Common Stock and $0.07 per share on the Class B Common Stock. The dividend will be payable on December 1, 2023, to shareholders of record as of November 20, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
dividends
-
Rhea-AI Summary
Agilent Technologies to release Q4 fiscal year 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
-
Rhea-AI Summary
Agilent Technologies announces approval of net-zero greenhouse gas emissions targets
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
none
Rhea-AI Summary
Helzberg Diamonds expands assortment with new demi-fine jewelry collection from Scout & Lark, available in 30 stores and online exclusively at Helzberg Diamonds. Collection consists of over 120 items ranging from $79.99 to $699.99, crafted with modern materials. Offers options for younger and young-at-heart consumers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.82%
Tags
none
-
Rhea-AI Summary
Agilent Technologies, Inc. (NYSE: A) announces quarterly dividend of 22.5 cents per share of common stock to be paid on Oct. 25, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.14%
Tags
dividends
-
Rhea-AI Summary
Exact Sciences acquires Resolution Bioscience to enhance cancer treatment solutions
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
none
Rhea-AI Summary
Philip Binns named president of Agilent's Life Sciences and Applied Markets Group (LSAG)
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.61%
Tags
none
-
Rhea-AI Summary
Agilent Technologies receives IVDR certification for PD-L1 IHC 22C3 pharmDx, Code SK006
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
-
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) reports Q3 revenue of $1.67 billion, down 2.7% YoY. GAAP net income is $111 million, with EPS of $0.38, down 65% from Q3 2022. Non-GAAP net income is $422 million, with EPS of $1.43, up 7% YoY. Full-year revenue outlook adjusted to $6.80-$6.85 billion, representing a decline of 0.7% to flat growth. Fiscal year 2023 non-GAAP EPS estimated at $5.40-$5.43.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
Rhea-AI Summary
Agilent Technologies Inc. (NYSE: A) announced that Dr. Ajit Divakaruni of UCLA has received the Agilent 2023 Early Career Professor Award for his work in developing live cell analytical tools to advance biomanufacturing applications. His research focuses on energy metabolism and metabolic flexibility to control cell function and fate, with implications for early-stage drug development and cell-based therapeutics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none

FAQ

What is the current stock price of Agilent Technologies (A)?

The current stock price of Agilent Technologies (A) is $126.57 as of March 6, 2025.

What is the market cap of Agilent Technologies (A)?

The market cap of Agilent Technologies (A) is approximately 36.1B.

What does Agilent Technologies Inc. do?

Agilent provides laboratory instruments, software, services, and consumables for industries like life sciences, diagnostics, pharmaceuticals, and environmental testing.

What industries does Agilent serve?

Agilent serves a wide range of industries, including pharmaceuticals, environmental testing, food safety, medical diagnostics, and academic research.

How does Agilent generate revenue?

Agilent generates revenue through the sale of laboratory instruments, consumables, software, and services, with a significant portion coming from recurring consumables and service contracts.

What are Agilent's main business segments?

Agilent operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and CrossLab Group, which offers services and consumables.

What is Agilent's competitive advantage?

Agilent's competitive advantage lies in its comprehensive laboratory solutions, strong technological foundation, and ability to address global health and environmental challenges.

Where does Agilent operate geographically?

Agilent has a global presence, with significant operations in the United States and China, alongside other international markets.

What makes Agilent's solutions unique?

Agilent's solutions are designed to enhance laboratory efficiency across the entire workflow, from sample preparation to data analysis, enabling actionable insights and scientific breakthroughs.

Who are Agilent's primary customers?

Agilent's customers include biopharmaceutical companies, clinical labs, academic institutions, government agencies, and organizations in environmental and food safety industries.

What is the significance of Agilent's CrossLab Group?

The CrossLab Group ensures operational efficiency by providing consumables, services, and software that support laboratories throughout their workflow.

How does Agilent address global challenges?

Agilent focuses on solutions that tackle global health and environmental trends, helping customers address critical issues in sustainability, diagnostics, and scientific research.
Agilent Technologies Inc

NYSE:A

A Rankings

A Stock Data

36.08B
283.83M
0.28%
91.26%
1.2%
Diagnostics & Research
Laboratory Analytical Instruments
Link
United States
SANTA CLARA